Superluminous Devices Versus Low-Level Laser for Temporomandibular Disorders
The aim of this study is to compare the pain intensity reduction between the mean radiation doses per session of gallium-aluminum-arsenide (GaAIAs) laser with superluminous diodes (SLD) in four of the most common pain-related chronic temporomandibular disorders (TMD) - local myalgia, myofascial pain...
Guardado en:
Autores principales: | , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Sciendo
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/f683496aff67435fb1fc3656034faf4f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:f683496aff67435fb1fc3656034faf4f |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:f683496aff67435fb1fc3656034faf4f2021-12-02T19:11:32ZSuperluminous Devices Versus Low-Level Laser for Temporomandibular Disorders0324-175010.2478/amb-2018-0002https://doaj.org/article/f683496aff67435fb1fc3656034faf4f2018-03-01T00:00:00Zhttps://doi.org/10.2478/amb-2018-0002https://doaj.org/toc/0324-1750The aim of this study is to compare the pain intensity reduction between the mean radiation doses per session of gallium-aluminum-arsenide (GaAIAs) laser with superluminous diodes (SLD) in four of the most common pain-related chronic temporomandibular disorders (TMD) - local myalgia, myofascial pain, myofascial pain with a referral, and arthralgia. This study was implemented on 124 patients with pain-related temporomandibular disorders according to the DC/TMD criteria. We applied trigger point oriented near-infrared laser (785 nm, 100 s, 8 J/cm2) and SLD cluster sessions (the cluster is composed of 49 SLDs with a combination of visible red (633 nm) and infrared (880 nm) diodes, 200 mW, 300 s, 8 J/cm2) for the temporomandibular joints and the affected muscles. Patients were evaluated at the start of the treatment, and after the 6th session of combined phototherapy. The pain intensity scores were measured according to the Visual Analogue Scale (VAS). Our results show that the most statistically manifested pain reduction is found for the SLD dose, р = 0,000118, followed by the overall dose (laser plus SLD); р = 0,001031, and the laser dose; р = 0,030942 (ANOVA dispersion analyses). Consequently, it can be concluded that myalgia is better treated through lower doses of red light compared to infrared laser doses because SLDs combine the prooxidative effect of photons with 633 nm wavelength, a large area of exposure, sufficient tissue penetration, and some positive warming thermal impact of the SLD clusters.Sveshtarov VasilNencheva-Sveshtarova S.Grozdanova R.Prodanova K.Sciendoarticletemporomandibular pain-related disorderslow-level laser therapysuperluminous clustersMedicineRENActa Medica Bulgarica, Vol 45, Iss 1, Pp 11-15 (2018) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
temporomandibular pain-related disorders low-level laser therapy superluminous clusters Medicine R |
spellingShingle |
temporomandibular pain-related disorders low-level laser therapy superluminous clusters Medicine R Sveshtarov Vasil Nencheva-Sveshtarova S. Grozdanova R. Prodanova K. Superluminous Devices Versus Low-Level Laser for Temporomandibular Disorders |
description |
The aim of this study is to compare the pain intensity reduction between the mean radiation doses per session of gallium-aluminum-arsenide (GaAIAs) laser with superluminous diodes (SLD) in four of the most common pain-related chronic temporomandibular disorders (TMD) - local myalgia, myofascial pain, myofascial pain with a referral, and arthralgia. This study was implemented on 124 patients with pain-related temporomandibular disorders according to the DC/TMD criteria. We applied trigger point oriented near-infrared laser (785 nm, 100 s, 8 J/cm2) and SLD cluster sessions (the cluster is composed of 49 SLDs with a combination of visible red (633 nm) and infrared (880 nm) diodes, 200 mW, 300 s, 8 J/cm2) for the temporomandibular joints and the affected muscles. Patients were evaluated at the start of the treatment, and after the 6th session of combined phototherapy. The pain intensity scores were measured according to the Visual Analogue Scale (VAS). Our results show that the most statistically manifested pain reduction is found for the SLD dose, р = 0,000118, followed by the overall dose (laser plus SLD); р = 0,001031, and the laser dose; р = 0,030942 (ANOVA dispersion analyses). Consequently, it can be concluded that myalgia is better treated through lower doses of red light compared to infrared laser doses because SLDs combine the prooxidative effect of photons with 633 nm wavelength, a large area of exposure, sufficient tissue penetration, and some positive warming thermal impact of the SLD clusters. |
format |
article |
author |
Sveshtarov Vasil Nencheva-Sveshtarova S. Grozdanova R. Prodanova K. |
author_facet |
Sveshtarov Vasil Nencheva-Sveshtarova S. Grozdanova R. Prodanova K. |
author_sort |
Sveshtarov Vasil |
title |
Superluminous Devices Versus Low-Level Laser for Temporomandibular Disorders |
title_short |
Superluminous Devices Versus Low-Level Laser for Temporomandibular Disorders |
title_full |
Superluminous Devices Versus Low-Level Laser for Temporomandibular Disorders |
title_fullStr |
Superluminous Devices Versus Low-Level Laser for Temporomandibular Disorders |
title_full_unstemmed |
Superluminous Devices Versus Low-Level Laser for Temporomandibular Disorders |
title_sort |
superluminous devices versus low-level laser for temporomandibular disorders |
publisher |
Sciendo |
publishDate |
2018 |
url |
https://doaj.org/article/f683496aff67435fb1fc3656034faf4f |
work_keys_str_mv |
AT sveshtarovvasil superluminousdevicesversuslowlevellaserfortemporomandibulardisorders AT nenchevasveshtarovas superluminousdevicesversuslowlevellaserfortemporomandibulardisorders AT grozdanovar superluminousdevicesversuslowlevellaserfortemporomandibulardisorders AT prodanovak superluminousdevicesversuslowlevellaserfortemporomandibulardisorders |
_version_ |
1718377124454203392 |